查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825636

2025年全球血液市场报告

Blood Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年血液市场规模将强劲成长，到2029年将达到112亿美元，复合年增长率为6.1%。预测期内的成长归因于有利的政府法规、老年人口的增长、捐血意识的提高、输血数量的增加以及门诊手术中心（ASCS）的增加。预测期内的主要趋势包括输血和血液筛检设备的进步、电脑化免疫测量、智慧血库库存管理系统、技术创新以及精确的温度监测和控制。

未来五年6.1%的成长预测较先前的预测略有下降，下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。贸易摩擦可能导致荷兰和巴西开发的采血袋和白血球滤器价格上涨，从而给血液供应带来挑战，增加血液中心的营运成本，扰乱美国的输血医疗。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响，贸易摩擦的影响可能会更加广泛。

预计手术数量的增加将推动血液市场的成长。这种增长是由医疗技术的进步、人口老化以及慢性病盛行率的上升所推动的。血液在手术中起着至关重要的作用，包括提供氧气和营养，帮助血液凝固以减少出血，并增强免疫反应以抵抗感染疾病。例如，2023 年 12 月，澳洲健康与福利研究所报告称，2022-2023 年有 735,500 名患者从公立医院择期手术候补名单中入院接受手术，比 2021-2022 年增加了 18%。因此，手术数量的激增正在推动血液市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球血液：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球血液市场：成长率分析
  • 全球血液市场表现：规模与成长，2019-2024
  • 全球血液市场预测：2024-2029年及2034年规模与成长
  • 全球血液市场：总目标市场（TAM）

第六章 市场细分

  • 全球血液市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 血液采集和处理
  • 血浆成分采集
  • 血型鑑定产品
  • 血液筛检产品
  • 全球血液市场：依交付方式、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 点滴解决方案
  • 凝胶
  • 喷
  • 生物医学密封剂
  • 全球血液市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 血液和血库
  • 诊断实验室
  • 门诊手术中心
  • 医院
  • 其他最终用户
  • 全球血液市场：按血液采集和处理（按类型）细分，实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 采血袋
  • 血液处理套件
  • 血液分离系统
  • 捐血套件
  • 全球血液市场：依血浆成分收集细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 血浆采集套件
  • 自动血浆采集系统
  • 血浆冷冻库和储存设备
  • 全球血液学市场：血型检测产品细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 血型试剂
  • 血型鑑定试剂套件（手动和自动）
  • 血型分析解决方案
  • 全球血液市场：按血液筛检产品细分（按类型）、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 血液筛检试剂
  • 血液筛检系统（自动和手动）
  • 传染病检查套件
  • 血红素检测套组

第七章 区域和国家分析

  • 全球血液市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球血液市场：按国家划分、实际结果和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 血液市场：竞争格局
  • 血液市场：公司简介
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Danaher Corp.
  • Merck KGaA
  • Asahi Kasei Medical Co. Ltd.
  • Henry Schein Inc.
  • Medline Industries Inc.
  • B. Braun Melsungen AG
  • Grifols SA
  • Terumo Corp.
  • Nipro Corp.
  • QuidelOrtho Corp.
  • Bio Rad Laboratories Inc.
  • LivaNova PLC
  • Haemonetics Corp.
  • Macopharma
  • DIAGAST SAS

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年血液市场：提供新机会的国家
  • 2029 年血液市场：细分领域带来新机会
  • 2029 年血液市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r29629u

Blood is a crucial bodily fluid essential for the proper functioning of organs. It is a complex mixture of components, including red blood cells, white blood cells, platelets, and plasma, which are vital for maintaining health and facilitating medical treatments.

The primary blood-related products include whole blood collection and processing, source plasma collection, blood typing products, and blood screening products. Whole blood collection and processing involves the collection, separation, and storage of whole blood, which encompasses red blood cells, white blood cells, platelets, and plasma. Various modes of delivery include infusion solutions, gels, sprays, and biomedical sealants. These products are utilized by a range of end users, such as blood and blood component banks, diagnostic laboratories, ambulatory surgical centers, hospitals, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The blood market research report is one of a series of new reports from The Business Research Company that provides blood market statistics, including blood industry global market size, regional shares, competitors with a blood market share, detailed blood market segments, market trends and opportunities, and any further data you may need to thrive in the blood industry. This blood market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The blood market size has grown strongly in recent years. It will grow from $8.32 billion in 2024 to $8.84 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to the surge in demand for blood and plasma, an increase in the number of surgeries, a growing global population, increasing incidence of chronic diseases, rising number of blood banks.

The blood market size is expected to see strong growth in the next few years. It will grow to $11.2 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to favorable government regulations, a rise in the geriatric population, rising awareness about blood donation, increase in blood transfusion, increasing number of ambulatory surgical centers (ASCS). Major trends in the forecast period include advancements in blood transfusion and blood screening instruments, computerized immunoassays, smart blood bank inventory control systems, technological innovations, precise temperature monitoring and control.

The forecast of 6.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. transfusion medicine by inflating prices of blood collection bags and leukoreduction filters developed in the Netherlands and Brazil, resulting in blood supply challenges and higher blood center operational expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in the number of surgeries is projected to boost the growth of the blood market. This increase is attributed to advancements in medical technology, an aging population, and a higher incidence of chronic diseases. Blood plays a critical role in surgeries by delivering oxygen and nutrients, aiding clotting to control bleeding, and enhancing the immune response to fight infections. For example, in December 2023, the Australian Institute of Health and Welfare reported that in 2022-2023, 735,500 patients were admitted for surgery from public hospital elective surgery waiting lists, an 18% increase from 2021-2022. Hence, the surge in surgeries is driving growth in the blood market.

Key players in the blood market are focusing on developing advanced blood transfusion technologies, such as plasma collection systems, to enhance efficiency, improve donor safety, and boost the overall quality of blood products. A plasma collection system extracts plasma from a donor's blood by separating it from other components and returning the remaining components to the donor through plasmapheresis. For instance, in March 2022, Terumo Blood and Cell Technologies, a US-based company specializing in blood components and cellular technology, received Food and Drug Administration approval for the Rika Plasma Donation System (Rika). This next-generation plasma collection system aims to enhance the experience for plasma center staff and donors, featuring safety enhancements to minimize operator errors and complete plasma collection in 35 minutes or less. Rika ensures that no more than 200 milliliters of blood are outside the donor's body at any time and includes an advanced control system for operators.

In March 2023, Werfen, a Spain-based medical equipment manufacturer, acquired Immucor Inc. for $2 billion. This acquisition is intended to broaden Werfen's diagnostic solutions portfolio, particularly in specialized diagnostics, allowing it to offer a more comprehensive range of products to customers, including hospitals, blood banks, and clinical laboratories. Immucor Inc., a US-based company, develops, manufactures, and markets products used by hospitals, blood banks, and clinical laboratories to detect and identify blood properties prior to transfusion.

Major companies operating in the blood market are Cardinal Health Inc., Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic Plc, Danaher Corp., Merck KGaA, Asahi Kasei Medical Co. Ltd., Henry Schein Inc., Medline Industries Inc., B. Braun Melsungen AG, Grifols SA, Terumo Corp., Nipro Corp., QuidelOrtho Corp., Bio Rad Laboratories Inc., LivaNova PLC, Haemonetics Corp., Macopharma, DIAGAST SAS, BAG Health Care GmbH, Kawasumi Laboratories America Inc

North America was the largest region in the blood market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the blood market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood market consists of sales of blood bags, blood glucose analyzers, blood collection tubes, and blood transfusion sets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Whole Blood Collection And Processing; Source Plasma Collection; Blood Typing Products; Blood Screening Products
  • 2) By Mode of Delivery: Infusion Solutions; Gels; Sprays; Biomedical Sealants
  • 3) By End User: Blood And Blood Component Bank; Diagnostic Laboratories; Ambulatory Surgical Centers; Hospitals; Other End Users
  • Subsegments:
  • 1) By Whole Blood Collection And Processing: Blood Collection Bags; Blood Processing Kits; Blood Separation Systems; Blood Donation Kits
  • 2) By Source Plasma Collection: Plasma Collection Kits; Automated Plasma Collection Systems; Plasma Freezers And Storage Equipment
  • 3) By Blood Typing Products: Blood Typing Reagents; Blood Typing Kits (Manual And Automated); Blood Grouping Solutions
  • 4) By Blood Screening Products: Blood Screening Reagents; Blood Screening Systems (Automated And Manual); Infectious Disease Testing Kits; Hemoglobin Testing Kits
  • Companies Mentioned: Cardinal Health Inc.; Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Medtronic Plc; Danaher Corp.; Merck KGaA; Asahi Kasei Medical Co. Ltd.; Henry Schein Inc.; Medline Industries Inc.; B. Braun Melsungen AG; Grifols SA; Terumo Corp.; Nipro Corp.; QuidelOrtho Corp.; Bio Rad Laboratories Inc.; LivaNova PLC; Haemonetics Corp.; Macopharma; DIAGAST SAS; BAG Health Care GmbH; Kawasumi Laboratories America Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood Market Characteristics

3. Blood Market Trends And Strategies

4. Blood Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Blood Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Blood PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Blood Market Growth Rate Analysis
  • 5.4. Global Blood Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Blood Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Blood Total Addressable Market (TAM)

6. Blood Market Segmentation

  • 6.1. Global Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Whole Blood Collection And Processing
  • Source Plasma Collection
  • Blood Typing Products
  • Blood Screening Products
  • 6.2. Global Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infusion Solutions
  • Gels
  • Sprays
  • Biomedical Sealants
  • 6.3. Global Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood And Blood Component Bank
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers
  • Hospitals
  • Other End Users
  • 6.4. Global Blood Market, Sub-Segmentation Of Whole Blood Collection And Processing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Collection Bags
  • Blood Processing Kits
  • Blood Separation Systems
  • Blood Donation Kits
  • 6.5. Global Blood Market, Sub-Segmentation Of Source Plasma Collection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plasma Collection Kits
  • Automated Plasma Collection Systems
  • Plasma Freezers And Storage Equipment
  • 6.6. Global Blood Market, Sub-Segmentation Of Blood Typing Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Typing Reagents
  • Blood Typing Kits (Manual And Automated)
  • Blood Grouping Solutions
  • 6.7. Global Blood Market, Sub-Segmentation Of Blood Screening Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Screening Reagents
  • Blood Screening Systems (Automated And Manual)
  • Infectious Disease Testing Kits
  • Hemoglobin Testing Kits

7. Blood Market Regional And Country Analysis

  • 7.1. Global Blood Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Blood Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood Market

  • 8.1. Asia-Pacific Blood Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood Market

  • 9.1. China Blood Market Overview
  • 9.2. China Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood Market

  • 10.1. India Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood Market

  • 11.1. Japan Blood Market Overview
  • 11.2. Japan Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood Market

  • 12.1. Australia Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood Market

  • 13.1. Indonesia Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood Market

  • 14.1. South Korea Blood Market Overview
  • 14.2. South Korea Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood Market

  • 15.1. Western Europe Blood Market Overview
  • 15.2. Western Europe Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood Market

  • 16.1. UK Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood Market

  • 17.1. Germany Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood Market

  • 18.1. France Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood Market

  • 19.1. Italy Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood Market

  • 20.1. Spain Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood Market

  • 21.1. Eastern Europe Blood Market Overview
  • 21.2. Eastern Europe Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood Market

  • 22.1. Russia Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood Market

  • 23.1. North America Blood Market Overview
  • 23.2. North America Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood Market

  • 24.1. USA Blood Market Overview
  • 24.2. USA Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood Market

  • 25.1. Canada Blood Market Overview
  • 25.2. Canada Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood Market

  • 26.1. South America Blood Market Overview
  • 26.2. South America Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood Market

  • 27.1. Brazil Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood Market

  • 28.1. Middle East Blood Market Overview
  • 28.2. Middle East Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood Market

  • 29.1. Africa Blood Market Overview
  • 29.2. Africa Blood Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Blood Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Blood Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood Market Competitive Landscape And Company Profiles

  • 30.1. Blood Market Competitive Landscape
  • 30.2. Blood Market Company Profiles
    • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis

31. Blood Market Other Major And Innovative Companies

  • 31.1. Danaher Corp.
  • 31.2. Merck KGaA
  • 31.3. Asahi Kasei Medical Co. Ltd.
  • 31.4. Henry Schein Inc.
  • 31.5. Medline Industries Inc.
  • 31.6. B. Braun Melsungen AG
  • 31.7. Grifols SA
  • 31.8. Terumo Corp.
  • 31.9. Nipro Corp.
  • 31.10. QuidelOrtho Corp.
  • 31.11. Bio Rad Laboratories Inc.
  • 31.12. LivaNova PLC
  • 31.13. Haemonetics Corp.
  • 31.14. Macopharma
  • 31.15. DIAGAST SAS

32. Global Blood Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Market

34. Recent Developments In The Blood Market

35. Blood Market High Potential Countries, Segments and Strategies

  • 35.1 Blood Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Blood Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Blood Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer